Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 2 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
FAM117A Is a New Prognostic Marker of Lung Adenocarcinoma and Predicts Sensitivity to PD0332991.
Evid Based Complement Alternat Med. 2022 Mar 3;2022:3945446. doi: 10.1155/2022/3945446. eCollection 2022.
Evid Based Complement Alternat Med. 2022.
PMID: 35280504
Free PMC article.
Lung cancer is the second most common cancer and the leading cause for cancer mortality worldwide. ...The cell cycle transition from G1 to S phase was suppressed upon FAM117A overexpression and was promoted upon FAM117A knockdown. Accordingly, t …
Lung cancer is the second most common cancer and the leading cause for cancer mortality worldwide. ...The cell cycle tr …
A Six-Gene Prognostic and Predictive Radiotherapy-Based Signature for Early and Locally Advanced Stages in Non-Small-Cell Lung Cancer.
Peinado-Serrano J, Quintanal-Villalonga Á, Muñoz-Galvan S, Verdugo-Sivianes EM, Mateos JC, Ortiz-Gordillo MJ, Carnero A.
Peinado-Serrano J, et al.
Cancers (Basel). 2022 Apr 19;14(9):2054. doi: 10.3390/cancers14092054.
Cancers (Basel). 2022.
PMID: 35565183
Free PMC article.
Non-small-cell lung cancer (NSCLC) is the leading cause of cancer death worldwide, generating an enormous economic and social impact that has not stopped growing in recent years. Cancer treatment for this neoplasm usually includes surgery, chemotherapy, molec …
Non-small-cell lung cancer (NSCLC) is the leading cause of cancer death worldwide, generating an enormous economic and social …
Item in Clipboard
Identification of potential tumor antigens and immune subtypes for lung adenocarcinoma.
Bai M, Liu X, Wang L.
Bai M, et al.
Med Oncol. 2023 Feb 21;40(3):100. doi: 10.1007/s12032-023-01973-3.
Med Oncol. 2023.
PMID: 36809467
In lung adenocarcinoma (LUAD), tumor antigens and immune phenotypes are important for cancer immunotherapy. This study aims to identify potential tumor antigens and immune subtypes for LUAD. ...Then, we first identified four genes with copy number variation and mutation re …
In lung adenocarcinoma (LUAD), tumor antigens and immune phenotypes are important for cancer immunotherapy. This study aims to identi …
Item in Clipboard
Cite
Cite